Korea Investment Partners

Korea Investment Partners (KIP) is a prominent venture capital and private equity firm based in Seoul, South Korea, with over 30 years of experience in the industry. Established in 1986, KIP focuses on investing in innovative companies across various sectors, including biotechnology, healthcare, media, financial technology, and information technology. The firm has a diverse portfolio that includes notable companies such as Kakao, Naver, and YG Entertainment. KIP manages more than 20 venture and private equity funds, with total assets under management amounting to approximately $1.8 billion. In addition to its headquarters in Seoul, KIP operates offices in Shanghai, Beijing, and Sunnyvale, showcasing its commitment to global investment opportunities.

Kim Jong -hyun

Director

Jihyun An

Principal of Venture Group 2

In Jae Baek

Principal of Venture Group 1

Injae Baek

Senior Associate

Haksung Chang

Managing Director and Head, PE

Yan Hao Chong

Principal, Singapore

Doe-Young Choo

Director of Venture Group 2

Eun Ki Chung

Director of Venture Group 1

Yeong Mok Gil

Senior Principal

Hudson Kyung-sik Ho

Managing Partner and Head, China

Mahn Soon Hwang

CEO

Joon Hyun

Vice President

Sang Hyuk Jang

Principal

Leah Jiang

Investor

Eunjae Jung

Director of Venture Group 2

Jihoon Jung

Executive Director of Venture Group 1

Soon Ouk Jung

Executive Director of Venture Group 2

Seung-hi Kang

Director of Venture Group 1

Jun-Kyu Kang

Principal

Kun Ho Kim

Executive Director of Venture Group 2

Hwa Young Kim

Senior Associate and Venture Partner

Jae Hong Kim

Managing Director

Hee Jin Kyle Kim

Director of Venture Group 1

Chang Ho Kim

Managing Director

Sujin Kim

Executive Director of Venture Group 2

John MJ Kim

Principal

Yong Jae Kim

Executive Managing Director, Investment Operations

Yunjoon Kim

Managing Director of Venture Group 1

Dong Yeob Kim

Executive Director and Chief Investment Officer

Jaehong Kim

Managing Director

SuChan Kwon

Senior Associate

SU Chan Kwon

Principal of Venture Group 2

Byung Min Lee

Vice President and Director

Young Tak Lee

Director, Private Equity

Ji Soo Lee

Director of Venture Group 1

Michael Lee

Executive Director of Venture Group 1

Sangwoo Lee

Director - Investments

Sang-jin Lee

Principal

Dong-yeong Lee

Principal

Min Sik Park

Managing Director

Sang Ho Park

Executive Director

Sangjoon Park

Investor

Deok Joon Shin

Director

Deok Jun Shin

Senior Managing Director of Venture Group 1

Han Kil Son

Director of Venture Group 1

Dong Hyun Song

Executive Director of Venture Group 1

Benjamin Song

Principal of Venture Group 2

Dongwon Ellie Sung

Principal of Venture Group 2

Ping Wang

Associate Partner

Jerry Xu

Director and Principal

Clara Yoon

Principal

Past deals in API

Xpanner

Series A in 2023
Xpanner is a developer of a cloud-based construction management platform that enhances collaboration and efficiency within the construction industry. By integrating various construction technology products from leading global companies, Xpanner provides a unified platform that serves as a single point of data entry and access for all stakeholders involved in construction projects. This integration not only improves management efficiency but also boosts productivity by an average of 15%. Furthermore, Xpanner emphasizes safety and environmental, social, and governance (ESG) improvements through its smart solutions, contributing to better overall project outcomes and a more streamlined construction process.

CashWalk

Series A in 2023
Developer of a healthcare application designed to offer a mysterious pedometer that makes money by walking. The company's platform offers health management solutions to manage chronic diseases such as hypertension, hyperlipidemia, and diabetes, enabling users to have access to live a healthy life and earn rewards by walking.

Apposter

Series B in 2022
Apposter is a Korean-based interactive solutions company engaged in providing UI development, app development, and mobile business consultancy solutions to its customers. Apposter has released many mobile apps and solutions to the enterprise market including, Fotofly, Life Valley, and Tok Song.

Zamface

Series A in 2020
Operator of an application-based beauty platform intended to help people in analyzing the cosmetics they want to buy and the compatibility of their skin. The company's platform provides personal color diagnosis, makeup tutorials, reviews, and recommendations on beauty products from influencers, enabling users to find beauty products that suit their color.

ABL Bio

Series B in 2017
ABL Bio Inc. is a biotechnology research company based in Seongnam, South Korea, dedicated to the development of therapeutic drugs targeting immuno-oncology and neurodegenerative diseases. The company's drug pipeline includes ABL001, an innovative cancer immunotherapy, as well as antibody-drug conjugates (ADCs) and ABL301. ABL Bio aims to improve patient lives through collaboration and innovation, focusing on novel therapies that address significant medical needs in these challenging disease areas.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.